Financial news

Showing 1-6 of 6
8 November 2011
Interim Report 3, 2011

Business improvements on track

12 August 2011
Interim Report 2, 2011

Revenue down 1.4% (CER) and EBIT margin at 15.1% (CER) for the first 6 months

28 April 2011
Interim Report 1, 2011

Revenue growth in Q1; profit affected by exceptional expenses

30 March 2011
The Annual General Meeting of Nobel Biocare approves all proposals of the Board of Directors

Nobel Biocare Holding AG’s Annual General Meeting today endorsed all proposals put forward by the Board of Directors.

17 February 2011
Full year report 2010

Operational milestones achieved; financial performance behind

Showing 1-6 of 6 

Investor contacts

Süha Demokan

Süha Demokan

Head of Investor Relations

Nobel Biocare Management AG  
P.O. Box
CH - 8058 Zurich-Airport
Switzerland

+41 43 211 42 30

+41 79 430 81 46

+41 43 211 42 42

Give us your feedback!

Summarize your comments
Email